Stock BIOSTEM TECHNOLOGIES INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Biostem Technologies Inc

Equities

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Biostem Technologies Inc
05-14 Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M MT
2023 NovaBay to Commercialize BioStem's Amniotic Tissue Allograft MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments
NE
BioStem Technologies Innovative Wound-Care Treatments Steepen Its Growth Trajectory ($BSEM)
AQ
BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments ($BSEM)
AQ
BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers
AQ
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study
AQ
UPDATE -- PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion
AQ
BioStem Technologies to Sponsor MRO Better Half Dash
AQ
4 Stocks to Watch in the Booming Regenerative Medicine Market
AQ
Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M
MT
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
AQ
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
AQ
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent
AQ
BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts
AQ
BioStem Technologies to Present at the 2024 Planet MicroCap Showcase
AQ
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange
AQ
BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference
AQ
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
AQ
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
AQ
PRISM MarketView Spotlights BioStem Technologies in the Expanding Wound Care Market
AQ
Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Biostem Technologies Inc